The Effect of Osteopathic Manipulative Treatment on Recovery of Coronary Bypass Patients (CABGOMT)

This study has been completed.
Sponsor:
Information provided by:
Michigan State University
ClinicalTrials.gov Identifier:
NCT00504179
First received: July 17, 2007
Last updated: NA
Last verified: July 2007
History: No changes posted
  Purpose

The purpose of the study was to determine the effect on recovery after surgery of patients who received a standardized daily protocol of osteopathic manipulative treatment.Patients undergoing elective coronary artery bypass surgery were voluntarily enrolled in the study and assigned to one of three groups.One group received a standardized daily treatment protocol along with conventional care, another received daily similar placebo treatment with conventional care, and a final group received only conventional post surgical care.The research hypothesis was that daily treatment with osteopathic manipulative treatment would reduce hospital stay and hasten recovery from surgery.Persons in the treatment group had earlier discharge, and faster recovery of bowel function and basic mobility.


Condition Intervention
Cardiovascular Disease
Procedure: Osteopathic Manipulative Treatment

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: The Effect of Osteopathic Manipulative Treatment on Post-Operative Medical and Functional Recovery of Coronary Artery Bypass Graft Patients

Resource links provided by NLM:


Further study details as provided by Michigan State University:

Primary Outcome Measures:
  • Recovery of mobility, bowel function, and reduced length of hospital stay.

Enrollment: 53
Study Start Date: April 2001
Study Completion Date: October 2005
Detailed Description:

Fifty-three persons were voluntarily enrolled into this randomized, double-blinded placebo controlled trial to examine the effects of osteopathic manipulative treatment (OMT) on the post operative recovery of persons undergoing elective coronary artery bypass graft (CABG) surgery. Participants were assigned randomly to one of three cohorts: one with only conventiobnal treatment, one with a daily standardized protocol of OMT and a third with a daily time matched placebo OMT protocol.All patients received standard state of the art care consistent with national standards of post CABG care. The study showed favorable trends in terms of hospital length of stay , return of bowel function, and mobility.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Adults undergoing elective coronary artery bypass graft surgery who were patients of the same surgeon

Exclusion Criteria:

  • prior coronary artery bypass graft procedure
  • unstable psychiatric illness
  • chronic pain
  • open chest phenomenon
  • unforeseen peri or postoperative complications
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00504179

Locations
United States, Michigan
Ingham Regional Medical Center
Lansing, Michigan, United States, 48910
Sponsors and Collaborators
Michigan State University
Investigators
Principal Investigator: Michael Wieting Michigan State University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00504179     History of Changes
Other Study ID Numbers: WIETING061855
Study First Received: July 17, 2007
Last Updated: July 17, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by Michigan State University:
coronary artery bypass graft
osteopathic manipulative treatment
cardiovascular disease

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on September 18, 2014